For research use only
| Cat No. | ABC-X0312C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Fibroblast |
| Species | Human |
| Host Cell | NIH/3T3 |
| Source Organ | Embryo |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human NRAS (G12V) NIH/3T3 Cell Line allows functional studies of NRAS oncogenic activation and its role in tumor cell proliferation and drug response.
Human NRAS (G12V) NIH/3T3 Cell Line features stable expression of the G12V mutant NRAS gene. NIH/3T3 cells provide a sensitive background for oncogene-driven transformation assays.
Target
G12V is a hotspot mutation in NRAS, conferring constitutive activation and resistance to negative regulatory mechanisms. It is prevalent in melanoma and hematologic cancers.
AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0312C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Embryo |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | NIH/3T3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
This model supports detailed studies on NRAS G12V oncogenic mechanisms, therapeutic target validation, and resistance development to RAS pathway inhibitors.